Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$3,815 Mln
Revenue (TTM)
$1,164 Mln
Net Profit (TTM)
$0 Mln
ROE
0.2 %
ROCE
-- %
P/E Ratio
49.7
P/B Ratio
6.3
Industry P/E
--
EV/EBITDA
13.1
Div. Yield
0 %
Debt to Equity
3.8
Book Value
$2.1
EPS
$0.3
Face value
--
Shares outstanding
284,392,079
CFO
$775.32 Mln
EBITDA
$2,104.67 Mln
Net Profit
$-129.10 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sotera Health Co (SHC)
| -23.3 | -22.5 | -20.9 | 12.8 | -9.2 | -12.0 | -- |
|
BSE Sensex
| -12.4 | -11.4 | -12.2 | -1.5 | 8.6 | 8.6 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Sotera Health Co (SHC)
| 28.9 | -18.7 | 102.3 | -64.6 | -14.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sotera Health Co (SHC)
|
13.5 | 3,815.1 | 1,163.6 | 78.0 | 26.1 | 15.4 | 49.7 | 6.3 |
| 14.3 | 3,315.2 | 3,125.0 | -262.7 | 0.9 | -313.2 | -- | 20.5 | |
| 381.9 | 5,670.0 | 2,530.0 | 265.2 | 14.2 | 25.3 | 21.9 | 5.6 | |
| 54.1 | 2,697.1 | 941.5 | 105.7 | 14.5 | 29.4 | 25.8 | 7.2 | |
| 97.9 | 10,098.8 | 5,935.2 | 566.2 | 18.1 | 25.1 | 18.1 | 4.1 | |
| 23.5 | 5,434.1 | 2,347.6 | 128.4 | 4.9 | 25.2 | 46.7 | 10.0 | |
| 29.5 | 4,649.3 | 5,649.5 | 207.6 | 7.0 | 15.2 | 23.1 | 3.5 | |
| 21.8 | 2,681.6 | 2,122.8 | 22.9 | 1.9 | 0 | 120.4 | 3.6 | |
| 61.9 | 4,818.9 | 2,040.2 | -18.7 | 5.0 | -1.9 | -- | 4.4 | |
| 204.5 | 12,186.8 | 5,057.8 | 344.0 | 9.2 | 16.9 | 36 | 5.5 |
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and... Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio. Read more
Chairman & CEO
Mr. Michael B. Petras Jr.
Chairman & CEO
Mr. Michael B. Petras Jr.
Headquarters
Broadview Heights, OH
Website
The share price of Sotera Health Co (SHC) is $13.53 (NASDAQ) as of 19-Mar-2026 10:39 EDT. Sotera Health Co (SHC) has given a return of -9.24% in the last 3 years.
The P/E ratio of Sotera Health Co (SHC) is 49.69 times as on 13-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
64.82
|
8.34
|
|
2024
|
87.79
|
9.63
|
|
2023
|
92.93
|
10.76
|
|
2022
|
-10.00
|
6.67
|
|
2021
|
56.37
|
11.24
|
The 52-week high and low of Sotera Health Co (SHC) are Rs 19.85 and Rs 9.53 as of 19-Mar-2026.
Sotera Health Co (SHC) has a market capitalisation of $ 3,815 Mln as on 13-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Sotera Health Co (SHC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.